AboutMark Larson

Mark leads research and development, supporting organizational transition to value-based care with a focus across the clinical enterprise. He is a thought leader in performance strategy for emerging workforce, consumerism, and innovative care delivery models and frequently networks with industry leaders, actively interprets industry and consumer trends, and oversees content development for Sg2 publications, conference materials, webinars, tools and analytics.

Revered for his thought leadership, Mark collaborates on consulting engagements and frequently presents at Sg2 conferences, on-site client meetings and webinars, and national industry conferences. He also routinely guides executives and strategy leaders in the application of Sg2 Intelligence and analytics to develop successful performance strategies. With nearly 25 years of health care finance, operations, strategy and systems experience, Mark has successfully implemented cost-savings programs and advised senior leadership on performance strategy development efforts at more than 100 major health institutions across the country.

Before joining Sg2, Mark was the regional director of consulting for Cardinal Health. He led the development of many process improvement projects and innovative, information-based tools, including a balanced scorecard to measure financial performance, process improvement, customer satisfaction, and learning and growth initiatives.

Previously, Mark held various managerial positions. At Cardinal Health and Baxter, he served as a finance and operations manager, overseeing the national direction, training and communication of processes, measurements and financial modeling in cost management services.

Mark holds an MBA from DePaul University and earned a BA with a double major in business administration and computer science from Coe College.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube